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Objectives: With COVID-19 infections resulting in death according to a hierarchy of risks, with age and
pre-existing health conditions enhancing disease severity, the objective of this study is to estimate the
condition-specific case fatality ratio (CFR) for different subpopulations in Italy.
Study design: The design of the study was to estimate the ‘pre-existing comorbidity’-conditional CFR to
eventually explain the mortality risk variability reported around in different countries.
Methods: We use the available information on pre-existing health conditions identified for deceased
patients ‘positive with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)’ in Italy. We (i)
estimated the total number of deaths for different pre-existing health conditions categories and (ii)
calculated a conditional CFR based upon the number of comorbidities before SARS-CoV-2 infection.
Results: Our results show a 0.6% conditional CFR for a population with zero pre-existing pathology,
increasing to 13.9% for a population diagnosed with one and more pre-existing health conditions.
Conclusions: Condition-specific mortality risks are important to be evaluated during the COVID-19
pandemic, with potential elements to explain the CFR variability around the globe. A careful postmor-
tem examination of deceased cases to differentiate death ‘caused by COVID-19’ from death ‘positive with
SARS-CoV-2’ is therefore urgently needed and will likely improve our understanding of the COVID-19
mortality risk and virus pathogenicity.
© 2020 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.In December 2019, a severe respiratory syndrome (COVID-19)
caused by a new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was identified in China1 and spread rapidly around
the globe. COVID-19 was declared a pandemic by the World Health
Organization (WHO) in March, 2020. As of the date of preparation
of this manuscript, more than 8 million cases were confirmed with
about 450 thousand deaths and a global case fatality ratio (CFR) of
approximately 5.5%.2 The CFR is the proportion of deceased cases
over the total number of persons diagnosed with a disease during
the course of the outbreak. The CFR is often used as a disease
severity indicator. Many viral diseases affecting humans have a
well-established CFR such as seasonal influenza (<0.1%)3 and un-
vaccinated measles (1e3%),4 Severe acute respiratory syndrome -
SARS (15%)5 and Middle Eastern Respiratory Syndrome - MERS
(34.4%),6 for example, with a pandemic potential without effectivePovo, Trento, Italy.
h. Published by Elsevier Ltd. All ricontrol measuers in place. As testing capacities have increased,
symptomatic cases of lower severity have been detected producing
a slow decline in global COVID-19 CFR. Yet, the national CFR varies
around the world. As of this writing, Qatar has a CFR less than 1%,
South Korea around 2.5%, and Germany 4.7%, compared with 14.5%
in Italy and the United Kingdom and approximately 19% in France.2
And why do these reported CFR differ? Do differences relate to
differences in population susceptibility to SARS-CoV-2 infection?
Because COVID-19 is a new virus, it is likely that overall population
susceptibility to infection might be similar while susceptibility to
disease expression might differ. Infection rates may be controlled
by social distancing and crowding, while the force of infection may
be controlled by many factors. Assumptions concerning these var-
iables are used in most modeling approaches used to guide public
health authorities during the COVID-19 pandemic.
Many other fundamental questions could be raised such as the
capacity of the health systems to copewith a new infectious disease
or even the overall health condition of a population, but toghts reserved.
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tion to be answered is how are the COVID-19 deceased cases re-
ported around the globe? Is it done in a standard format, via a
postmortem examination7 to differentiate death ‘caused by COVID-
19’, defined for surveillance purposes as a death resulting from a
clinically compatible illness, from death ‘positivewith SARS-CoV-2’,
a conditional effect of high viral transmissibility?
Starting on May 13, 2020, the ‘Coronavirus disease situation
reports’ from the WHO highlight the importance of defining
COVID-19 death following the international guidelines for certifi-
cation and its classification of COVID-19 as cause of death by
confirmed laboratory testing or clinical or epidemiological diag-
nosis.2 However, the CFR is still reported without considering dif-
ferences in subpopulations.
Italy, the first hard-hit country in Europe, reported on June 11,
2020, a population CFR of 14.5% after reaching 34,167 deaths among
236,142 confirmed cases ‘positive with SARS-CoV-2’.8 Approxi-
mately 85% of reported deaths occurred in individuals older than 70
years, but the CFR changes when evaluated in subpopulations. The
average age-group stratified CFR (number of deaths in the age
group divided by the number of confirmed cases in the same age
group) is approximately 33%.9 However, the cumulative number of
death from inpatients aged 70 years and older tested ‘positive with
SARS-CoV-2’ over the infection level of the whole population
(quantified by the cumulative notified incidences in Italy up to June
11, 2020) leads to a much lower conditional CFR of 12% for in-
dividuals aged 70 years and older .
Data about the pre-existing health conditions of all infected in-
dividuals in Italy are not available to measure the specific CFR for
each comorbidity group; however, a detailed report characterizing
the deceased patientswhichwere tested positivewith SARS-CoV-2 is
published, once a week, by the Istituto Superiore di Sanita in Italy.
The studied population is divided into groups with ‘0 pre-existing
pathology’, ‘1 pre-existing pathology’, ‘2 pre-existing pathologies’,
and ‘3 ormore pre-existing pathologies’ diagnosed before the patient
became infected with SARS-CoV-2.10 We note that this report10 does
not show the correlation between pre-existing pathologies and age
but states that 1.1% of the deceased individuals positive with SARS-
CoV-2 were younger than 50 years. Among those, 83 deceased pa-
tients were younger than 40 years, which are expected to be in the
category with a low risk of death ‘caused by COVID-19’. However, forTable 1
Estimation of conditional COVID-19 CFR in Italy, by June 11, 2020. Addressing the numb
estimated using stratified (upper part) and aggregated (lower part) information for popu
Italy by June 11, 2020 e current CFR ¼ 14,5%
Stratified information by June 11, 2020
Pre-existing pathologies
diagnosed before the patient
became infected with










the number of p
health condition
category11
0 pathology 144 4.19%
1 pathology 505 14.69%
2 pathologies 738 21.47%
3 or more pathologies 2051 59.66%
Aggregated information by June 11, 2020
At most 1 pathology (zero and 1 pre-existing
condition prior SARS-COV-2 infection)
649 18.88%
Two or more pathologies (two, three, or
more pre-existing conditions prior
SARS-COV-2 infection)
2789 81.12%
At least 1 pathology (one, two, and three
or more pre-existing conditions prior
SARS-COV-2 infection)
3294 95.81%
CFR, case fatality ratio.
19this group, approximately 75% (N¼ 62) of individuals were suffering
from severe pre-existing health conditions against 17% (N¼ 14) who
did not have any important underlying health condition. Medical
records were not available for the remaining patients.
From this perspective, the ‘pre-existing comorbidity’-condi-
tional CFR, which is defined here as the number of deceased cases
with one or more pre-existing health conditions before SARS-CoV-
2 infection divided by the total number of detected infected cases in
the population, is a relevant and important measure to understand
the current differences between the CFR reported around the globe.
Up to June 11, 2020, 3438 medical records for deceased cases
tested positive with SARS-CoV-2 were analyzed, with 4.1% of the
deceased cases classified with zero pre-existing pathologies versus
approximately 60% of the deceased patients sufferingwith 3 ormore
pre-existing pathologies prior SARS-CoV-2 infection. By assuming
that the deceased case characterization in Italy is performed
randomly as the deaths are reported, we use the stratified data for
individuals with zero, one, two, three, or more pre-existing condi-
tions to estimate the total number of deaths expected in each cate-
gory in the population. The ‘pre-existing comorbidity’-conditional
CFR was obtained by dividing the total estimated number of deaths
from each category by the overall confirmed cases in the population.
Our results have shown that mortality risk varies significantly
between the number of pre-existing pathology groups, with
CFR ¼ 0.6% for individuals with 0 pre-existing pathology,
CFR¼ 2.1% for individuals with 1 pre-existing pathology, CFR¼ 3.1%
for individuals with 2 pre-existing pathologies, and CFR ¼ 8.6% for
individuals with 3 or more pre-existing pathologies (refer upper
part of Table 1). By using the aggregated data, the higher CFR es-
timations were obtained for the group of individuals diagnosed
with two or more pre-existing health conditions (CFR ¼ 11.7%) and
the group of individuals with at least one pre-existing health con-
ditions (CFR¼ 13.9%), refer lower part of Table 1, which are closer to
the currently reported CFR in Italy and comparable with the current
CFR reported in the United Kingdom,2 for example, where patient
postmortem examination is not used as tool of investigation before
death notification.7 However, for the group of individuals diag-
nosed with zero and one pre-existing health conditions prior SARS-
CoV-2 infection (at most one), the CFR is low (CFR ¼ 2.7%) and
comparable with the current CFR reported in Norway2 and the







Estimated cumulative number of
death in Italy for each pre-existing
health condition category (with
34167 notified deceased cases in
the whole population of Italy on
June 11, 202011)
Estimated current conditional
CRF (with 236142 confirmed
cases in the whole population








M. Aguiar and N. Stollenwerk Public Health 188 (2020) 18e20In Italy, the most common reported underlying health condi-
tions in deceased cases are hypertension (60%) and diabetes
(30%).10 Knowing that middle-age patients have high risk to have
been already diagnosed with at least one of those chronic, but
treatable, diseases,13 our results suggest that the biological COVID-
19 CFR, that is, the disease-induced death by SARS-CoV-2 infection,
could be much lower than the currently reported value. CRF mea-
surement reported as a unique number for the whole population,
without considering differences in subpopulations, will over-
estimate the biological disease-induced mortality rate.
Condition-specific mortality risks are important to be evaluated
during this pandemic, with potential elements to explain the CFR
variance in different countries. A careful postmortem examination
of deceased cases to differentiate death ‘caused by COVID-19’ from
death ‘positive with SARS-CoV-2’ is therefore urgently needed and
will likely improve our understanding of the SARS-CoV-2 patho-
genicity. As those estimations are not final until the characteriza-
tion of the deceased cases is finished and data on all medical
records for all infected individuals in the populations would
become available, this exercise has the objective to discuss the
urgent need of using a more standardized method for deceased
notification across many nations during the COVID-19 pandemic.Author statements
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